157.30
-10.22 (-6.1%)
-10.22 (-6.1%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 11,801,340 |
|
|||||
| News | (2) | ||||||
| Day High | 171.2543 | Low High |
|||||
| Day Low | 157.29 | ||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -10.22 | -6.1% | 157.30 | 20:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 166.23 | 157.29 | 171.2543 | 160.07 | 167.52 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 180,385 | 11,801,340 | $ 161.90 | $ 1,910,644,381 | - | 117.3411 - 497.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:42 | formt | 100 | $ 157.30 | USD |
Period:
Draw Mode:
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 63.78B | 405.45M | 297.32M | $ 803.40M | $ 523.25M | -1.95 | 10.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -847.58k | 5.70% |
Moderna News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 204.01 | 212.76 | 157.29 | 182.74 | 10,812,464 | -46.71 | -22.9% |
| 1 Month | 242.99 | 259.1989 | 157.29 | 219.40 | 9,214,359 | -85.69 | -35.26% |
| 3 Months | 344.49 | 376.4118 | 157.29 | 268.58 | 12,271,270 | -187.19 | -54.34% |
| 6 Months | 298.87 | 497.17 | 157.29 | 340.83 | 14,417,691 | -141.57 | -47.37% |
| 1 Year | 125.20 | 497.17 | 117.3411 | 274.28 | 12,867,072 | 32.10 | 25.64% |
| 3 Years | 16.62 | 497.17 | 11.54 | 150.21 | 11,099,201 | 140.68 | 846.45% |
| 5 Years | 22.00 | 497.17 | 11.54 | 149.37 | 10,760,992 | 135.30 | 615.0% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 24 mRNA development programs as of early 2021, with 13 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |